Protective effect and molecular mechanisms of human non-neutralizing cross-reactive spike antibodies elicited by SARS-CoV-2 mRNA vaccination
Jordan J. Clark(Icahn School of Medicine at Mount Sinai), Florian Krammer(Semmelweis University), Juan Manuel Carreño(Icahn School of Medicine at Mount Sinai), Stylianos Bournazos(Rockefeller University), Ali H. Ellebedy(Washington University in St. Louis), Iden A. Sapse(Icahn School of Medicine at Mount Sinai), Irene Hoxie(Icahn School of Medicine at Mount Sinai), Fatima Amanat(Icahn School of Medicine at Mount Sinai), Ariel Raskin(Icahn School of Medicine at Mount Sinai), Goran Bajic(Icahn School of Medicine at Mount Sinai), Johnstone Tcheou(Icahn School of Medicine at Mount Sinai), Gagandeep Singh(Icahn School of Medicine at Mount Sinai), Robert Andreata‐Santos(Universidade Federal de São Paulo), Irene González‐Domínguez(Icahn School of Medicine at Mount Sinai), Viviana Simon(Icahn School of Medicine at Mount Sinai), Jeremy S. Yong(Icahn School of Medicine at Mount Sinai), Weina Sun(Icahn School of Medicine at Mount Sinai), Julia E. Edgar(Rockefeller University), Daniel C. Adelsberg(Icahn School of Medicine at Mount Sinai)
Cited by 9
Related Papers
Influenza
|Nature Reviews Disease Primers|2018|1.5k
Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies
|Nature Medicine|2021|1k
Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization
|Cell Host & Microbe|2021|851
Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine
|New England Journal of Medicine|2021|803